Confirmatory interleukin-1 receptor antagonist trial in severe sepsis-Reference-Cited by-同舟云学术

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis

Published:1997-07 Issue:7 Volume:25 Page:1115-1124
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Opal Steven M.,Fisher Charles J.,Dhainaut Jean-Francois A.,Vincent Jean-Louis,Brase Rainer,Lowry Stephen F.,Sadoff Jerald C.,Slotman Gus J.,Levy Howard,Balk Robert A.,Shelly Maire P.,Pribble John P.,LaBrecque John F.,Lookabaugh Janice,Donovan Hugh,Dubin Howard,Baughman Robert,Norman James,DeMaria Eric,Matzel Klaus,Abraham Edward,Seneff Michael

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference31 articles.

1. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.

2. Interleukin-1 and interleukin-1 antagonism

3. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor

4. Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.

Cited by 766 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sepsis-Induced Immunosuppression: The Role of Co-inhibitory Molecules;Science Journal of Clinical Medicine;2024-08-30

2. The role of trained immunity in sepsis;Frontiers in Immunology;2024-08-15

3. Charting the course for improved outcomes in chronic critical illness: therapeutic strategies for persistent inflammation, immunosuppression, and catabolism syndrome (PICS);British Journal of Anaesthesia;2024-08

4. Combined therapy with IL-1 and JAK inhibitors in a patient with the NLRP1 gene mutation and a complex inflammatory phenotype;Journal of Allergy and Clinical Immunology: Global;2024-08

5. Evolving Paradigms in Sepsis Management: A Narrative Review;Cells;2024-07-09